PT UBC Medical Indonesia Tbk (IDX:LABS)
145.00
-6.00 (-3.97%)
May 26, 2026, 4:04 PM WIB
IDX:LABS Balance Sheet
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 18,419 | 41,165 | 42,554 | 3,617 | 827.53 | 11,598 |
Cash & Short-Term Investments | 18,419 | 41,165 | 42,554 | 3,617 | 827.53 | 11,598 |
Cash Growth | -36.64% | -3.26% | 1076.53% | 337.07% | -92.86% | - |
Receivables | 42,969 | 32,928 | 19,585 | 33,326 | 17,015 | 7,438 |
Inventory | 77,244 | 78,067 | 74,038 | 57,286 | 35,383 | 30,498 |
Prepaid Expenses | 2,380 | 1,642 | 3,561 | 202.54 | 266.63 | 154.22 |
Other Current Assets | 31,079 | 28,643 | 19,307 | 16,464 | 6,182 | 9,177 |
Total Current Assets | 172,090 | 182,444 | 159,045 | 110,896 | 59,674 | 58,864 |
Property, Plant & Equipment | 33,151 | 33,714 | 33,452 | 36,104 | 25,000 | 31,041 |
Long-Term Investments | - | - | - | - | 5,952 | 2,430 |
Other Intangible Assets | 3,654 | 4,411 | 5,339 | 6,147 | - | - |
Long-Term Deferred Tax Assets | 4,299 | 4,299 | 2,897 | 2,734 | 3,158 | 2,565 |
Long-Term Deferred Charges | 1,333 | 1,333 | 2,489 | 4,383 | 5,587 | - |
Other Long-Term Assets | 4,083 | 1,987 | 376.6 | 23 | 1,174 | 93.44 |
Total Assets | 218,610 | 228,187 | 203,599 | 160,287 | 108,730 | 94,994 |
Accounts Payable | 32,798 | 45,478 | 26,463 | 38,474 | 35,041 | 32,022 |
Accrued Expenses | 2,425 | 748.71 | 586.48 | 2,901 | 1,283 | 512.1 |
Short-Term Debt | 24,818 | 24,736 | 23,973 | 21,322 | 18,563 | 24,000 |
Current Portion of Long-Term Debt | 597.65 | 1,012 | 1,029 | 368.19 | 487.91 | 373.55 |
Current Portion of Leases | 89.81 | 89.81 | 252.71 | 229.44 | 182.16 | 284.81 |
Current Income Taxes Payable | 364.72 | 167.32 | 312 | 1,128 | 905.87 | 3,614 |
Current Unearned Revenue | - | - | - | 6,926 | - | 9,282 |
Other Current Liabilities | 1,525 | 36.1 | 6.97 | 18,831 | 4,020 | 13,732 |
Total Current Liabilities | 62,619 | 72,268 | 52,623 | 90,179 | 60,482 | 83,820 |
Long-Term Debt | 1,327 | 1,665 | 10,597 | 19,159 | 297.2 | 1,416 |
Long-Term Leases | - | - | 89.81 | 342.52 | - | - |
Pension & Post-Retirement Benefits | 1,791 | 1,791 | 1,535 | 1,246 | 480.26 | 525.58 |
Total Liabilities | 65,736 | 75,723 | 64,845 | 110,927 | 61,260 | 85,761 |
Common Stock | 79,000 | 79,000 | 79,000 | 46,837 | 46,837 | 11,432 |
Additional Paid-In Capital | 54,157 | 54,157 | 54,157 | - | - | - |
Retained Earnings | 19,138 | 18,728 | 5,221 | 2,269 | 79.02 | -2,755 |
Comprehensive Income & Other | 578.55 | 578.55 | 375.77 | 253.93 | 554.01 | 555.17 |
Total Common Equity | 152,874 | 152,464 | 138,755 | 49,360 | 47,470 | 9,232 |
Minority Interest | 0.05 | 0.06 | 0.1 | 0.08 | 1 | - |
Shareholders' Equity | 152,874 | 152,464 | 138,755 | 49,360 | 47,471 | 9,232 |
Total Liabilities & Equity | 218,610 | 228,187 | 203,599 | 160,287 | 108,730 | 94,994 |
Total Debt | 26,832 | 27,503 | 35,941 | 41,422 | 19,530 | 26,074 |
Net Cash (Debt) | -8,413 | 13,662 | 6,612 | -37,805 | -18,703 | -14,477 |
Net Cash Growth | - | 106.61% | - | - | - | - |
Net Cash Per Share | -2.13 | 3.46 | 1.67 | -16.06 | - | - |
Filing Date Shares Outstanding | 3,950 | 3,950 | 3,950 | 3,250 | - | - |
Total Common Shares Outstanding | 3,950 | 3,950 | 3,950 | 3,250 | - | - |
Working Capital | 109,471 | 110,176 | 106,422 | 20,717 | -807.81 | -24,956 |
Book Value Per Share | 38.70 | 38.60 | 35.13 | 15.19 | - | - |
Tangible Book Value | 149,220 | 148,053 | 133,415 | 43,213 | 47,470 | 9,232 |
Tangible Book Value Per Share | 37.78 | 37.48 | 33.78 | 13.30 | - | - |
Buildings | 4,355 | 4,355 | 4,355 | 4,096 | - | - |
Machinery | 90,001 | 87,421 | 78,786 | 70,293 | 54,282 | 52,385 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.